EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming

Childress, A. R. et al. · 2026

bioRxiv / medRxiv · Papers · License: Open Access · 2026

cancer biology

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 619186
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.